Unraveling the mysteries of Parkinson's disease, a complex brain network has emerged as a potential key to understanding its diverse symptoms. The SCAN network, a recently discovered brain region, may hold the answer to why Parkinson's affects more than just movement.
Parkinson's disease is not just about tremors and walking difficulties. It can also impact sleep, smell, digestion, and cognitive functions. This is where the SCAN network comes into play. Researchers at WashU Medicine in St. Louis identified this network, which connects movement and thinking, as a crucial area affected by Parkinson's.
Hesheng Liu, a brain scientist from Changping Laboratory and Peking University, describes it as a "tunnel jam" that disrupts communication between the body and mind. This finding aligns with growing evidence that Parkinson's is a network disorder, impacting various brain areas beyond those that control specific movements.
But here's where it gets controversial: other degenerative brain diseases, like Alzheimer's and ALS, affect different brain networks. Alzheimer's reduces connectivity in the default mode network, impacting memory and self-awareness, while ALS primarily damages the motor system network, controlling movement. Understanding these unique network disruptions is crucial for developing targeted treatments.
Parkinson's, affecting about 1 million people in the US, presents a unique challenge with its varied symptoms. For instance, a person unable to stand may suddenly leap in an emergency, or a patient who can walk may freeze during a conversation. These symptoms suggest that the disease affects not only motor circuits but also circuits involved in thinking and emotion.
For decades, scientists struggled to explain this link. Then, in 2023, a breakthrough discovery revealed the somato-cognitive action network (SCAN), connecting movement and thinking. Liu's team believed SCAN could explain the odd symptoms in Parkinson's, and their MRI study on over 800 brains confirmed it.
Patients with Parkinson's showed abnormally strong connections between the SCAN network and brain areas affected by the disease. Instead of improving communication, these strong connections caused a traffic jam, blocking signals. Deep brain stimulation, a treatment delivering electrical pulses, improved this by lowering connectivity and allowing normal brain function.
All effective treatments for Parkinson's seem to act on this SCAN circuitry, with identical results. This challenges the conventional wisdom that Parkinson's is solely a movement disorder. People with Parkinson's often experience a range of symptoms beyond voluntary movement, including chronic constipation, reduced smell, sleep disorders, memory lapses, and fatigue.
These symptoms can be misinterpreted, leading to stigma. Doctors recall patients like a man who suddenly dropped in blood pressure when standing, causing him to fall. People thought he was drunk, but a medical diagnosis explained his behavior. The SCAN network's involvement in involuntary functions like heart rate, digestion, and blood pressure may explain these odd symptoms.
Current treatments for Parkinson's don't address these non-motor issues, but future treatments might, by targeting the SCAN network. This study highlights the importance of understanding brain networks in developing effective treatments for Parkinson's and other degenerative brain diseases.
What are your thoughts on this new understanding of Parkinson's? Do you think targeting the SCAN network could be a game-changer for treatment? Share your insights in the comments!
